30 vials of cryopreserved HepaRG cells (Catalog Number: HPRGC10)

The National Institutes of Health, Office of Logistics and Acquisition Operations, is procuring 30 vials of cryopreserved HepaRG cells (Catalog Number: HPRGC10) on a non-competitive basis, with responses due September 1, 2026. The award will be made to Life Technologies Corporation without competition under FAR 12.603 for commercial products.

The National Institute of Environmental Health Sciences, Division of Translational Toxicology, Mechanistic Toxicology Branch, requires these immortalized progenitor cells to model toxicity-induced liver injury in humans using 3D microphysiological systems. HepaRG cells are selected for their superior functionality in modeling human liver cell and tissue physiology compared to conventional liver cell lines and their demonstrated capability to model liver fibrosis when combined with stellate cells and monocytes. Place of performance is Research Triangle Park, NC (NIH/NIEHS, 111 TW Alexander Drive, Research Triangle Park, NC 27709).

This procurement is not set-aside for small business and is classified under NAICS 325414, Biological Product (except Diagnostic) Manufacturing, and PSC 6505, Drugs and Biologicals. The acquisition is not expected to exceed the simplified acquisition threshold. Offerors must register in SAM with a valid UEI and provide TIN and business size certification. Price quotations must include unit price, list price, shipping and handling, delivery timeframe, delivery terms, prompt payment discount terms, F.O.B. point, and product catalog numbers. Evaluation factors may include past performance, technical capability, warranty, and maintenance availability. Point of contact is Francisca Wagstaff at wagstaff@nih.gov.